BLIS Technologies (NZSE:BLT) EPS (Basic) : NZ$0.00 (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies EPS (Basic)?

BLIS Technologies's basic earnings per share (Basic EPS) for the six months ended in Mar. 2024 was NZ$0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.00.

BLIS Technologies's EPS (Diluted) for the six months ended in Mar. 2024 was NZ$0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.00.

BLIS Technologies's EPS without NRI for the six months ended in Mar. 2024 was NZ$0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, BLIS Technologies's highest 3-Year average EPS without NRI Growth Rate was 55.00% per year. The lowest was -40.10% per year. And the median was 32.70% per year.

BLIS Technologies EPS (Basic) Historical Data

The historical data trend for BLIS Technologies's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies EPS (Basic) Chart

BLIS Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

Get a 7-Day Free Trial

BLIS Technologies Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															-	-	-	-	-

BLIS Technologies EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

BLIS Technologies's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0.646	-	0)	/	1273.937
	=	0.00

BLIS Technologies's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(1.316	-	0)	/	1274.072
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.00

BLIS Technologies (NZSE:BLT) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

BLIS Technologies EPS (Basic) Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

BLIS Technologies (NZSE:BLT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016

Website

https://www.blis.co.nz

BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets two strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 both of which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).